Avrobio, Inc. completed its merger with Tectonic Therapeutic, Inc., resulting in a name change to Tectonic Therapeutic, Inc. and a reverse stock split. The company also entered into a Contingent Value Rights Agreement and indemnification agreements, and appointed new directors and executive officers.